4-1 BB ligand in inflammatory diseases

Details for Australian Patent Application No. 2007318219 (hide)

Owner The Scripps Research Institute

Inventors Kang, Young Jun; Han, Jiahuai

Agent Pizzeys

Pub. Number AU-A-2007318219

PCT Pub. Number WO2008/057171

Priority 60/917,561 11.05.07 US; 60/852,022 16.10.06 US

Filing date 16 October 2007

Wipo publication date 15 May 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/057171 Priority application(s): WO2008/057171

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007318220-Organic compounds

2007318210-Native (telopeptide) placental collagen compositions